
How a Hidden Bacterial Fragment Is Rewriting the Science of Lung Fibrosis
Researchers identified corisin as a direct driver of pulmonary fibrosis, opening the door to new antibody-based treatments.
Research on bacteria, viruses, fungi and the microbiome, and how they affect human health.

Researchers identified corisin as a direct driver of pulmonary fibrosis, opening the door to new antibody-based treatments.

Latest UK life sciences news on AI diagnosis, cancer vaccines and infectious disease research, with implications for future NHS care.

Mayo Clinic researchers identify gut bacteria signals that may help explain and treat IBS-related constipation.

England may expand MenB vaccination to all 15-year-olds on the NHS, aiming to strengthen teenage protection against meningococcal disease.

West Nile virus death in the Netherlands raises concern over possible silent spread of the mosquito-borne infection in Europe.

A personalized mRNA melanoma vaccine has shown late-stage trial success, raising hopes for future cancer immunotherapy.

Oxford’s Ebola vaccine trial and an NHS sepsis wearable push show how fast UK life sciences is evolving.

Oxford begins a UK trial of a rapidly developed Ebola vaccine targeting the Bundibugyo strain amid an ongoing outbreak.

Nature examines the peptide injection boom and warns that wellness hype is outpacing scientific evidence.

Johns Hopkins’ AI sepsis warning system wins FDA clearance, highlighting the growing role of AI in early hospital infection detection.